DJ Abbott Laboratories Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slipped 2.09% to $82.56 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.19% to 7,412.84 and the Dow Jones Industrial Average rising 0.19% to 49,704.47.
This was the stock's second consecutive day of losses.
Abbott Laboratories closed 40.63% below its 52-week high of $139.06, which the company reached on June 24th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.05% to $221.43, Pfizer Inc. $(PFE)$ rose 0.51% to $25.81, and Merck & Co. Inc. $(MRK)$ fell 0.09% to $111.28.
Trading volume (16.2 M) eclipsed its 50-day average volume of 12.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 11, 2026 16:36 ET (20:36 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments